Mycobacterium tuberculosisand Rifampin Resistance, United Kingdom

Author:

Sam I-Ching1,Drobniewski Francis1,More Philip1,Kemp Melanie1,Brown Timothy1

Affiliation:

1. Health Protection Agency, London, United Kingdom

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference27 articles.

1. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: third global report/the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance, 1999–2002. Geneva: The Organization; 2004.

2. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK.;Drobniewski;Thorax,2002

3. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.;Park;Int J Tuberc Lung Dis,1998

4. An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital.;Breathnach;J Hosp Infect,1998

5. National plan for reliable tuberculosis laboratory services using a systems approach. Recommendations from CDC and the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services.;Shinnick;MMWR Recomm Rep,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3